Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AVEO Pharmaceuticals
Biotech
After surprise FDA win, Aveo reverts to normal as partner splits
After getting an FDA approval for its long-suffering cancer med from the FDA this month, Aveo’s brief positive news was upset by reverting to type.
Ben Adams
Mar 15, 2021 8:55am
Aveo regains full rights to ficlatuzumab as partner splits
Sep 8, 2020 8:54am
Aveo gives up on ficlatuzumab in AML, citing COVID-19
Mar 30, 2020 7:15am
FDA tells Aveo no, again, for tivozanib
Nov 4, 2019 7:43am
Aveo tanks after FDA feedback on OS data delays tivozanib filing
Feb 1, 2019 10:25am
Novartis dumps Aveo drug as relationship sours
Jul 3, 2018 9:38am
